Too Broad Solutions: A VC Breakdown of Bad Pitch Deck Examples

VCs cannot fund solutions they cannot define. Master the Specificity Inversion Framework to replace vague category marketing with a VC-ready product mechanism.

2.9 EXAMPLES: GOOD VS BAD PROBLEM & SOLUTION SLIDES (VC ANALYSIS)

3/2/20269 min read

Too Broad Solutions: A VC Breakdown of Bad Pitch Deck Examples
Too Broad Solutions: A VC Breakdown of Bad Pitch Deck Examples

Too Broad Solutions: A VC Breakdown of Bad Pitch Deck Examples

A B2B infrastructure founder walked into a Series A partner meeting with $2.1M ARR, a 130% NRR, and a customer list that included three Fortune 500 procurement divisions. He did not get a term sheet. His Problem Slide was precise. His traction was real. His Solution Slide described a platform that, in the partner's own post-meeting notes, "could have been submitted by any of fourteen companies currently in our pipeline."

That is the specific failure this breakdown addresses. Not a solution that is wrong — a solution that is so broad it is indistinguishable. Broad solutions do not fail because they are inaccurate. They fail because they are unfalsifiable. A VC cannot evaluate a solution they cannot define, cannot differentiate a company whose core value proposition matches a category description, and cannot write an investment thesis around a slide that reads like a market map rather than a product. This analysis sits alongside the VC analysis of good vs. bad Problem and Solution Slides and goes into the specific structural mechanics of why broad solution framing is a silent Series A disqualifier — with teardowns and rebuilds across four real failure patterns.

Why a Broad Solution Slide Is More Dangerous Than a Weak One

A weak solution raises a flag. A broad solution raises no flag at all — it reads as professionally written, category-aware, and superficially competent. That is precisely what makes it lethal. The VC does not stop at the slide and identify the failure. They continue reading, carrying a vague solution frame into every subsequent slide, and the contamination accumulates invisibly.

Here is the specific mechanism. When a VC reads a broad Solution Slide, their analyst logic cannot form a falsifiable hypothesis about the product. They cannot answer the question: "Under what conditions would this solution fail to deliver the outcome it claims?" That question is not academic — it is the foundation of every diligence process. If the solution is "an AI-powered platform that streamlines operations and drives efficiency," there are no conditions under which it definitionally fails, because it has not defined success with enough specificity to be tested. A solution that cannot be falsified cannot be underwritten.

The secondary damage runs to competitive positioning. In a partner meeting, a VC is simultaneously evaluating your company against every company in the same category they have reviewed in the past 90 days. A broad solution description does not differentiate — it assimilates. You become a composite of your competitors rather than a distinct investment thesis. I have reviewed sixteen Solution Slides in the past six months where the founding team's actual product was genuinely differentiated at the feature and outcome level, but the slide language was so categorical that the product was functionally invisible behind the category description. Twelve of those decks did not advance past the analyst screen.

The psychological origin is almost always one of two errors: strategic hedging (the founder deliberately broadens the solution to avoid appearing too niche, fearing that specificity will limit the perceived TAM) or language borrowing (the founder pulls solution language from competitor websites, investor reports, or category definitions, importing the vocabulary of the market rather than the vocabulary of the product). Both errors produce the same outcome — a solution that belongs to the category rather than to the company.

The Breadth Penalty: What a Broad Solution Costs Across the Diligence Stack

The damage from a broad Solution Slide is not confined to one slide. It distributes across the entire deck and compounds at each stage of VC evaluation.

Stage 1 — The Solution Slide fails the differentiation test. In 2025, the median US Series A is being contested across a pool of companies where category-level descriptions are the norm, not the exception. Top-tier funds have responded by running explicit differentiation screens at the analyst level before any deck reaches a partner. A solution framed at the category level does not pass that screen — not because the product is undifferentiated, but because the slide does not demonstrate differentiation with enough specificity to be evaluated.

Stage 2 — The competitive moat becomes undefendable. When the VC reaches the competitive landscape slide, they compare your solution description to your competitors' descriptions. If both use the language of the category — "streamlined workflows," "unified data layer," "intelligent automation" — there is no slide-level evidence of a moat. The moat may exist at the product level, but the founder has not translated it into the pitch. The VC cannot give credit for differentiation they cannot see.

Stage 3 — Pricing becomes disconnected from value. A broad solution cannot be priced against a specific outcome. If the solution "improves operational efficiency," the buyer's willingness to pay is uncalibrated — because the outcome is undefined. This makes the VC's pricing validation impossible. They cannot assess whether your $24K ACV is justified by the value delivered, because the value delivered has not been specified. As of early 2026, top-tier US funds are requiring explicit value-to-price ratio validation as part of Series A diligence — a practice that was common but not universal in 2022–2023 vintages. A broad Solution Slide fails that validation before diligence even begins.

The three-point cost breakdown:

  • Differentiation collapse: The solution is evaluated as a category participant, not a category leader — compressing the defensible valuation multiple

  • Moat erosion: Without a specific mechanism of value delivery, the VC cannot identify a technical, structural, or network-based barrier to replication

  • Pricing validation failure: An unspecified outcome cannot be priced, validated, or used to defend ACV assumptions in an investment committee

The Broad Solution Reconstruction Protocol: Four Patterns Rebuilt to VC Standard

Each teardown follows the Specificity Inversion Method: identify the categorical language, replace it with mechanism-level language, and reattach the solution directly to the problem's named failure point.

Breakdown 1 — The Category Description Collapse

Broad Solution Slide: "[Product] is an AI-powered supply chain visibility platform that helps enterprise operations teams make smarter decisions faster — delivering real-time insights, predictive analytics, and seamless integration across your existing tech stack."

What the VC sees: Four categorical descriptors (AI-powered, visibility, real-time insights, predictive analytics), one integration claim, zero mechanism of value delivery. This slide describes a market category, not a product. Every major supply chain software vendor uses at least three of these five phrases in their homepage copy.

VC-Ready Reconstruction: "[Product] detects carrier departure delays at origin within 90 minutes of occurrence — automatically recalculating downstream delivery windows and triggering rerouting options ranked by cost and SLA impact. Operations teams receive a decision, not a dashboard. Average reduction in SLA breach rate across current accounts: 34%. Average time-to-decision on rerouting: 11 minutes, down from 4.2 hours."

What changed: The platform became a product. "Real-time insights" became a 90-minute detection window. "Smarter decisions faster" became 11 minutes vs. 4.2 hours. "Predictive analytics" became a ranked rerouting output. Every categorical phrase was replaced with a specific mechanism, a specific actor, and a specific measurable outcome.

Breakdown 2 — The Feature Stack Broadcast

Broad Solution Slide: "[Product] gives finance teams a unified platform for budgeting, forecasting, reporting, scenario planning, and variance analysis — all in one place, with real-time data sync and collaboration built in."

What the VC sees: A feature list that describes the entire FP&A software category. "All in one place" is a category claim, not a product claim. "Real-time data sync" is a table-stakes expectation, not a differentiator. This slide could have been submitted by Anaplan, Pigment, Cube, or any of eleven Series A FP&A companies currently in market.

VC-Ready Reconstruction: "[Product] closes the specific gap between ERP actuals and board-ready forecasts for finance teams at $15M–$80M revenue companies — without requiring a BI tool, a data warehouse, or a financial analyst to build the bridge manually. A CFO connects the ERP on day one. A board-ready variance report is generated by day three. The manual reconciliation layer that currently costs finance teams an average of 22 hours per month-end cycle is eliminated at the architectural level, not worked around."

What changed: The feature list is gone. The specific ICP is named ($15M–$80M). The specific failure point addressed (manual reconciliation between ERP and board reporting) is explicit. The timeline (day one connection, day three output) is concrete. The differentiation (eliminates the reconciliation layer architecturally) is falsifiable — a VC can test whether that claim is true.

Breakdown 3 — The Aspiration Platform

Broad Solution Slide: "[Product] empowers HR leaders to build better teams, reduce turnover, and create a culture of high performance — using data-driven insights to drive smarter people decisions at every level of the organisation."

What the VC sees: Three aspirational outcomes (better teams, reduced turnover, high performance), one methodology claim (data-driven), and zero structural mechanism. "Empowers HR leaders" is a marketing sentence. "Smarter people decisions" is undefined. This slide describes what an HR leader wants to feel, not what the product does to produce a measurable outcome.

VC-Ready Reconstruction: "[Product] identifies flight-risk employees 60–90 days before resignation using a predictive model built on role tenure, internal mobility signals, manager interaction patterns, and compensation benchmarks — without requiring surveys, self-reporting, or HR intervention to generate the signal. For a 500-person company with a 22% annual attrition rate, the model flags an average of 14 high-confidence flight-risk cases per quarter. Current customers report a 41% reduction in regrettable attrition within 12 months of deployment."

What changed: "Reduce turnover" became a 41% reduction in regrettable attrition with a 12-month timeline. "Data-driven insights" became four named signal inputs. "Smarter people decisions" became 14 high-confidence cases per quarter with a 60–90 day lead window. The VC can now calculate the economic value of that outcome for a 500-person customer and validate whether the ACV is defensible against that value.

Breakdown 4 — The Integration Claim

Broad Solution Slide: "[Product] connects your entire GTM stack — CRM, MAP, sales engagement, and data enrichment tools — into a single revenue intelligence layer that gives revenue teams the visibility they need to hit number."

What the VC sees: A connectivity claim (connects your stack), a category descriptor (revenue intelligence layer), and a vague outcome (visibility to hit number). "Hit number" is not a measurable outcome. "Visibility" is not a mechanism. This slide describes a middleware product without specifying what the middleware produces that does not exist today.

VC-Ready Reconstruction: "[Product] solves the signal attribution failure that occurs when a deal closes or churns without a traceable cause — by unifying CRM activity data, email engagement signals, and product usage events into a single account timeline, retroactively reconstructable to the first touch. Revenue leaders can identify, for the first time, which specific GTM motions produced closed-won outcomes versus closed-lost ones — at the rep level, the segment level, and the channel level. Current customers report a 28% improvement in pipeline-to-close conversion within two quarters of deployment, driven by reallocation of activity toward confirmed winning patterns."

What changed: "Revenue intelligence layer" became a specific attribution failure solved. "Visibility" became a retroactively reconstructable account timeline. "Hit number" became a 28% pipeline-to-close improvement driven by a named mechanism (reallocation toward winning patterns).

The Specificity Inversion Framework:

Step 1: Identify every adjective or category descriptor in your Solution Slide (AI-powered, unified, intelligent, seamless, real-time, data-driven) Step 2: For each one, ask: "What specifically does this mean for the named customer in the named failure scenario?" Step 3: Replace the descriptor with the answer to that question — expressed as a mechanism, a metric, or a timeline Step 4: Apply the falsifiability test — "Under what conditions would this solution fail to deliver this outcome?" If you cannot answer that, the solution is still too broad

Three Rebuilding Traps That Reintroduce Breadth After the Reconstruction

Trap 1 — Specificity in the headline, category language in the supporting copy. The headline now reads: "Detects carrier delays within 90 minutes and triggers ranked rerouting options." But the three bullets underneath it revert to: "Powered by machine learning," "seamlessly integrated," and "enterprise-ready scalability." Category language migrates to supporting copy after a headline rebuild. Audit every line, not just the primary statement.

Trap 2 — Quantifying the outcome without attributing the mechanism. The solution claims a 34% reduction in SLA breach rate. That is a specific, credible outcome. But if the slide does not explain how the product produces that reduction — what it does differently at the mechanism level — the VC cannot distinguish between a genuine structural outcome and a cherry-picked case study statistic. Outcome plus mechanism is the minimum standard. Outcome alone is still a broad claim dressed in a number.

Trap 3 — Narrowing the solution to match the problem but losing the expansion narrative. The reconstruction is now tightly scoped to a specific failure point for a specific ICP. The founder panics and adds a line about the broader platform vision to reassure the VC that the TAM is large enough. That line reintroduces breadth. The expansion narrative belongs on a dedicated traction or roadmap slide — not on the Solution Slide. Protect the specificity of the solution frame completely. Let the market size slide carry the TAM argument.

What Precision on the Solution Slide Recovers at the Term Sheet Table

A specific, mechanism-level Solution Slide does not just survive analyst pre-screening — it actively accelerates the diligence cycle by pre-answering the questions that broad solutions generate. When a VC analyst can read your Solution Slide and immediately identify the differentiated mechanism, the named beneficiary, and the quantified outcome, the post-meeting memo writes in a single draft. The IC question shifts from "what does this product actually do?" to "how defensible is the mechanism at scale?" That is a materially different conversation — and one that happens weeks faster in a diligence timeline that is already measuring founder runway in every week it extends. The complete system for building a solution frame that survives every stage of Series A diligence is inside the Series A pitch deck Problem and Solution Slide system.

The 16 VC-Quality AI Prompts inside the $5K Consultant Replacement Kit include the exact specificity inversion sequence used in this teardown — prompts that take your current broad Solution Slide language and reconstruct it at the mechanism level, with output calibrated to what a Series A analyst expects to see before the deck reaches a partner. The full Kit is $497. Deploy the reconstruction before your next deck goes out at the Series A solution slide rebuild system for founders in active fundraise.